Award
NIH Reporter #1K99AG103301-01
Therapeutic development to target tau using immunotherapy and CRISPR-based approaches
Recipient
University of North Carolina at Chapel Hill
Award Amount
$138,701.00
Ceiling
$138,701.00
Awarded
September 11, 2026
Identifier
1K99AG103301-01
NIH grant awarded for research on tau targeting in Alzheimer's disease using immunotherapy and CRISPR, managed by UNC Chapel Hill.
Description
This NIH grant opportunity supports research on tau protein targeting in Alzheimer's disease using immunotherapy and CRISPR-based approaches. The project is managed by the University of North Carolina at Chapel Hill and funded by the National Institute on Aging (NIA), part of the NIH.